This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Albert, M. L. Death-defying immunity: do apoptotic cells influence antigen processing and presentation? Nature Rev. Immunol. 4, 223–231 (2004).
Fonteneau, J. F. et al. Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells. Blood 102, 4448–4455 (2003).
Shen, L. & Rock, K. L. Cellular protein is the source of cross-priming antigen in vivo. Proc. Natl Acad. Sci. USA 101, 3035–3040 (2004).
Rodriguez, A., Regnault, A., Kleijmeer, M., Ricciardi-Castagnoli, P. & Amigorena, S. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nature Cell Biol. 1, 362–368 (1999).
Arrode, G. et al. Incoming human cytomegalovirus pp65 (UL83) contained in apoptotic infected fibroblasts is cross-presented to CD8+ T cells by dendritic cells. J. Virol. 74, 10018–10024 (2000).
Kotera, Y., Shimizu, K. & Mule, J. J. Comparative analysis of necrotic and apoptotic tumor cells as a source of antigen(s) in dendritic cell-based immunization. Cancer Res. 61, 8105–8109 (2001).
Kotera, Y., Fontenot, J. D., Pecher, G., Metzgar, R. S. & Finn, O. J. Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients. Cancer Res. 54, 2856–2860 (1994).
Larsson, M. et al. Activation of HIV-1 specific CD4+ and CD8+ T cells by human dendritic cells: roles of cross-presentation and non-infectious HIV-1 virus. AIDS 16, 1319–1329 (2002).
Subklewe, M., Paludan, C., Tsang, M. L., Steinman, R. M. & Münz, C. Dendritic cells cross-present latency gene products from Epstein–Barr virus-transformed B cells and expand tumor-reactive CD8+ killer T cells. J. Exp. Med. 193, 405–412 (2001).
O'Rourke, M. G. et al. Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine. Cancer Immunol. Immunother. 52, 387–395 (2003).
Geiger, J. D. et al. Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression. Cancer Res. 61, 8513–8519 (2001).
Scheffer, S. R. et al. Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo. Int. J. Cancer 103, 205–211 (2003).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bhardwaj, N., Larsson, M. Dead-cell-associated proteins are an important source of antigens for cross-presentation by dendritic cells. Nat Rev Immunol 4, 656 (2004). https://doi.org/10.1038/nri1308-c1
Issue date:
DOI: https://doi.org/10.1038/nri1308-c1